The potential role of GLP-1 receptor agonists in substance use disorders – a systematic review

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-02
DOI
https://doi.org/10.3389/fphar.2025.1702448
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The potential role of GLP-1 receptor agonists in substance use disorders – a systematic review

D. S. Choi, K. M. Völker, N. L. Bormann, B. L. H. Prechtl
Frontiers in Pharmacology
Diabetes Treatment and Management
article

The potential role of GLP-1 receptor agonists in substance use disorders – a systematic review

D. S. Choi, K. M. Völker, N. L. Bormann, B. L. H. Prechtl
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Mayo Clinic (US), Nuremberg Hospital (DE), Paracelsus Medizinische Privatuniversität (DE)
Good health and well-being
Openalex Percentile: Top 99%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The potential role of GLP-1 receptor agonists in substance use disorders – a systematic review — D. S. Choi, K. M. Völker, et al. · Frontiers in Pharmacology (2026) | TGRS Research Map | TGRS